Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia
Clinical trial NCT01147341 · COMPLETED
Trial details
- NCT number
- NCT01147341
- Sponsor
- Michael Schiff, MD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.